tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

TOVX Stock Latest News

Theriva Biologics Reports Positive VIRAGE Phase 2b Results
Company AnnouncementsTheriva Biologics Reports Positive VIRAGE Phase 2b Results
19d ago
8K
TOVX
Theriva Biologics says IDMC considers VCN-01 to be well tolerated
PremiumThe Fly
Theriva Biologics says IDMC considers VCN-01 to be well tolerated
19d ago
TOVX
Theriva Biologics Reports 2024 Financial Results and Progress
PremiumCompany Announcements
Theriva Biologics Reports 2024 Financial Results and Progress
1M ago
TOVX
Theriva Biologics files to sell 7.69M shares of common stock, warrants
PremiumThe Fly
Theriva Biologics files to sell 7.69M shares of common stock, warrants
4M ago
TOVX
Theriva Biologics Advances VCN-01 with FDA Guidance
PremiumCompany Announcements
Theriva Biologics Advances VCN-01 with FDA Guidance
5M ago
8K
TOVX
Theriva Biologics announces U.S. FDA guidance of Phase 3 study design
PremiumThe FlyTheriva Biologics announces U.S. FDA guidance of Phase 3 study design
5M ago
TOVX
Theriva Biologics Highlights Key Achievements in Q3 2024
Premium
Company Announcements
Theriva Biologics Highlights Key Achievements in Q3 2024
5M ago
TOVX
Theriva Biologics price target lowered to $6 from $25 at Maxim
Premium
The Fly
Theriva Biologics price target lowered to $6 from $25 at Maxim
5M ago
TOVX
Theriva Biologics reports Q3 EPS ($6.81) vs. ($4.85) last year
PremiumThe Fly
Theriva Biologics reports Q3 EPS ($6.81) vs. ($4.85) last year
5M ago
TOVX
3 Penny Stocks to Watch Now, 11/5/24
PremiumMarket News
3 Penny Stocks to Watch Now, 11/5/24
6M ago
ATHA
TOVX
Theriva Biologics Expands Stock Plans and Share Authority
PremiumCompany Announcements
Theriva Biologics Expands Stock Plans and Share Authority
6M ago
8K
TOVX
Theriva Biologics picked as finalist in competition for Merck KGaA’s EMEA grant
PremiumThe Fly
Theriva Biologics picked as finalist in competition for Merck KGaA’s EMEA grant
6M ago
TOVX
Theriva Biologics Gains Orphan Drug Status for VCN-01
PremiumCompany AnnouncementsTheriva Biologics Gains Orphan Drug Status for VCN-01
6M ago
8K
TOVX
Theriva announces orphan medicinal product designation by EMA to VCN-01
Premium
The Fly
Theriva announces orphan medicinal product designation by EMA to VCN-01
6M ago
TOVX
Theriva Biologics’ SYN-004 receives positive DSMC review in Phase 1/2 trial
Premium
The Fly
Theriva Biologics’ SYN-004 receives positive DSMC review in Phase 1/2 trial
7M ago
TOVX
Theriva Biologics Advances SYN-004 in Clinical Trial
PremiumCompany Announcements
Theriva Biologics Advances SYN-004 in Clinical Trial
7M ago
8K
TOVX
Theriva Biologics prices $2.5M public offering at $1.75 per share
PremiumThe Fly
Theriva Biologics prices $2.5M public offering at $1.75 per share
7M ago
TOVX
Theriva Biologics prices $2.5M public offering at $2.00 per share
PremiumThe Fly
Theriva Biologics prices $2.5M public offering at $2.00 per share
7M ago
TOVX
Correct: Theriva Biologics prices $2.5M public offering at $1.75 per share
PremiumThe Fly
Correct: Theriva Biologics prices $2.5M public offering at $1.75 per share
7M ago
TOVX
Theriva Biologics Advances VCN-01 in VIRAGE Phase 2b Trial
PremiumCompany AnnouncementsTheriva Biologics Advances VCN-01 in VIRAGE Phase 2b Trial
7M ago
8K
TOVX
Theriva Biologics achieves target patient enrollment in VIRAGE Phase 2b trial
Premium
The Fly
Theriva Biologics achieves target patient enrollment in VIRAGE Phase 2b trial
7M ago
TOVX
Theriva Biologics Secures Funding for Viral Therapy Innovation
Premium
Company Announcements
Theriva Biologics Secures Funding for Viral Therapy Innovation
7M ago
8K
TOVX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >